Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Teva Pharmaceutical Industries Limited (TEVA)

  • Business News
  • Aug. 26, 2025, 08:22 UTC
  • 5
  • 0 comments

Temenos Earns 2025 Great Place To Work Certification™ Across 10 Countries

Market reaction Comment Full text

Teva Pharmaceutical Industries Limited (TEVA)

  • Business News
  • Aug. 26, 2025, 08:21 UTC
  • 4
  • 0 comments

Robex remains on track for first gold at Kiniero in Q4 CY2025

Market reaction Comment Full text

Teva Pharmaceutical Industries Limited (TEVA)

  • Business News
  • Aug. 26, 2025, 08:16 UTC
  • 3
  • 0 comments

Sýn hf.: Afkoma Sýnar hf. á fyrri helmingi ársins 2025 - Fjárfestakynning

Market reaction Comment Full text

Teva Pharmaceutical Industries Limited (TEVA)

  • Business News
  • Aug. 26, 2025, 08:15 UTC
  • 3
  • 0 comments

RESULT OF RIKSBANK CERTIFICATE SALE

Market reaction Comment Full text

Teva Pharmaceutical Industries Limited (TEVA)

  • Business News
  • Aug. 26, 2025, 08:14 UTC
  • 3
  • 0 comments

Approved first supplement of the base prospectus of UAB “Atsinaujinančios energetikos investicijos”

Market reaction Comment Full text

Westlake Chemical Corporation (WLK)

  • Business News
  • Aug. 26, 2025, 07:30 UTC
  • 4
  • 0 comments

Westlake - Westlake Announces Acquisition of ACI Compounding Solutions Business

Market reaction Comment Full text

Westlake Chemical Corporation (WLK)

  • Business News
  • Aug. 26, 2025, 07:30 UTC
  • 3
  • 0 comments

Westlake Announces Acquisition of ACI Compounding Solutions Business

Market reaction Comment Full text

Gilead Sciences Inc (GILD)

  • Business News
  • Aug. 26, 2025, 07:00 UTC
  • 3
  • 0 comments

Gilead - European Commission Authorizes Twice-YearlyYeytuo® (Lenacapavir) for HIV Prevention

Market reaction Comment Full text

Gilead Sciences Inc (GILD)

  • Business News
  • Aug. 26, 2025, 07:00 UTC
  • 3
  • 0 comments

European Commission Authorizes Twice-Yearly Yeytuo® (Lenacapavir) for HIV Prevention

Market reaction Comment Full text

Celyad Oncology SA (CYADY)

  • Business News
  • Aug. 26, 2025, 06:29 UTC
  • 3
  • 0 comments

Celyad Oncology announces discontinuation of R&D activities

Market reaction Comment Full text

Smith & Nephew SNATS Inc (SNN)

  • Business News
  • Aug. 26, 2025, 06:12 UTC
  • 4
  • 0 comments

Smith+Nephew PLC Notification

Market reaction Comment Full text

Capricor Therapeutics Inc. (CAPR)

  • Business News
  • Aug. 26, 2025, 05:36 UTC
  • 3
  • 0 comments

CAPR Stockholders with Large Losses Should Contact Robbins LLP Before the Lead Plaintiff Deadline for Information About Leading the Capricor Therapeutics, Inc. Class Action Lawsuit

Market reaction Comment Full text

Spectrum Pharmaceuticals Inc (was acquised by Assertio Holdings, Inc (NASDAQ:ASRT) on 31/07/2023) (SPPI)

  • Business News
  • Aug. 26, 2025, 05:33 UTC
  • 3
  • 0 comments

SPPI New Lead Plaintiff Deadline: Contact Robbins LLP for Information About Leading the Class Action Against SPPI

Market reaction Comment Full text

Femasys Inc (FEMY)

  • Business News
  • Aug. 26, 2025, 03:44 UTC
  • 3
  • 0 comments

- Femasys Announces Pricing of $8.0 Million Underwritten Public Offering

Market reaction Comment Full text

Aoxin Q & M Dental Grp Limited (1D4)

  • Business News
  • Aug. 26, 2025, 02:52 UTC
  • 3
  • 0 comments

Q & M Dental Group (Singapore) Limited - Announcement

Market reaction Comment Full text
  • Previous
  • 248
  • 249
  • 250
  • 251
  • 252
  • Next

Search

News categories

  • Technical Exchange News(9979)
  • Event(412)
  • SEC News(169206)
  • FDA Approval(9390)
  • Company Report(721)
  • Business News(112785)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin